Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial

Authors

Rodney Dawson (ORCID: https://orcid.org/0000-0001-9804-1588)
Yongge Liu (ORCID: https://orcid.org/0000-0002-3982-4176)
Kim Narunsky
Andreas H. Diacon (ORCID: https://orcid.org/0000-0001-8641-6792)
Vineshree Mischka Moodley (ORCID: https://orcid.org/0000-0002-9494-5720)
Veronique de Jager (ORCID: https://orcid.org/0000-0001-6389-5575)
Kelly Wallace Stinson
Jeffrey Hafkin (ORCID: https://orcid.org/0000-0002-6690-3240)
Bo Zheng (ORCID: https://orcid.org/0000-0001-8576-1367)

Institutions

Pharmaceutical Product Development (United States) (US)
University of Cape Town (ZA)
Otsuka (United States) (US)
Task Applied Science (ZA)
Novel (Germany) (DE)
Ministry of Culture (PE)
Secretaria Municipal de Cultura (BR)
Otsuka (Germany) (DE)

Publication Details

Journal: The Lancet Infectious Diseases
Published: 2024-11-27
DOI: https://doi.org/10.1016/s1473-3099(24)00601-7
Citations: 10
Primary Topic: Tuberculosis Research and Epidemiology
Type: article
Field-Weighted Citation Impact: 3.89

Funders

Bill and Melinda Gates Foundation
Otsuka Pharmaceutical Development and Commercialization

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial

Rodney Dawson, Yongge Liu, Kim Narunsky, Andreas H. Diacon et al.

Nov 27, 2024

10 citations

The Lancet Infectious Diseases

Tuberculosis Research and Epidemiology

3.89

article

Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial

Rodney Dawson, Yongge Liu, Kim Narunsky, Andreas H. Diacon, Vineshree Mischka Moodley, Veronique de Jager, Kelly Wallace Stinson, Jeffrey Hafkin, Bo Zheng

November 27, 2024article en

10 citations

Abstract

No abstract available for this paper.

The Lancet Infectious DiseasesVol. 25(4)

Pharmaceutical Product Development (United States) (US), University of Cape Town (ZA), Otsuka (United States) (US), Task Applied Science (ZA), Novel (Germany) (DE), Ministry of Culture (PE), Secretaria Municipal de Cultura (BR), Otsuka (Germany) (DE)

Bill and Melinda Gates Foundation, Otsuka Pharmaceutical Development and Commercialization

Good health and well-being

Openalex Percentile: Top 6%

Tuberculosis Research and Epidemiology

3.89

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.